A Silent Threat Unveiled: Mycobacterium gordonae Catheter-Related Peritonitis in a Patient on Peritoneal Dialysis
- PMID: 39850194
- PMCID: PMC11753903
- DOI: 10.7759/cureus.76280
A Silent Threat Unveiled: Mycobacterium gordonae Catheter-Related Peritonitis in a Patient on Peritoneal Dialysis
Abstract
Infectious complications in peritoneal dialysis (PD) remain a constant challenge, with atypical pathogens posing significant risks. This case from Thailand highlights the rare occurrence of Mycobacterium gordonae, an often-overlooked non-tuberculous mycobacterium (NTM), as the causative agent in a catheter-related exit-site infection that progressed to peritonitis. Initially misattributed to Pseudomonas aeruginosa from preceding exit-site infections, M. gordonae was ultimately identified as the primary pathogen through multiple effluent cultures and advance polymerase chain reaction sequencing. This case underscores the importance of heightened clinical suspicion, early and accurate diagnosis, and timely interventions to prevent severe complications, including hemodialysis transfer.
Keywords: catheter-related infection; exit site infection; mycobacterium gordonae; non-tuberculous mycobacterium; peritoneal dialysis; peritonitis.
Copyright © 2024, Hein et al.
Conflict of interest statement
Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. - issued approval -. Chulalongkorn University does not require ethical approval for reporting individual cases or case series. Informed consent, in accordance with the Declaration of Helsinki, was obtained from all participants prior to enrolment. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: Prof. Talerngsak Kanjanabuch Faculty of Medicine, Chulalongkorn University 1873 Rama IV rd., Pathumwan, Bangkok 10130 Tax ID 0994000158041. Financial relationships: Talerngsak Kanjanabuch declare(s) personal fees from VISTERRA. consultancy fees . Talerngsak Kanjanabuch declare(s) a grant from Thailand Science research and Innovation Fund Chulalongkorn University, Royal College of Physicians of Thailand, Ratchadapiseksompotch Fund, Chulalongkorn University, Royal College of Physicians of Thailand, Kidney Foundation of Thailand . Talerngsak Kanjanabuch declare(s) speaking honoraria from AstraZeneca, Baxter Healthcare, Fresenius Medical Care. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures
References
-
- Mycobacterium gordonae: an unusual peritoneal pathogen in a patient undergoing continuous ambulatory peritoneal dialysis. London RD, Damsker B, Neibart EP, Knorr B, Bottone EJ. Am J Med. 1988;85:703–704. - PubMed
-
- Failure to cure Mycobacterium gordonae peritonitis associated with continuous ambulatory peritoneal dialysis. Harro C, Braden GL, Morris AB, Lipkowitz GS, Madden RL. Clin Infect Dis. 1997;24:955–957. - PubMed
-
- Successful treatment of Mycobacterium gordonae exit-site and tunnel infection by partial catheter reimplantation of the Tenckhoff catheter. Hirohama D, Ishibashi Y, Kawarazaki H, Kume H, Fujita T. Perit Dial Int. 2011;31:368–370. - PubMed
Publication types
LinkOut - more resources
Full Text Sources